PGI Rohtak to start phase-2 trial of Bharat Biotech`s COVID-19 vaccine
Published
Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech`s COVID-19 vaccine.
Full ArticlePublished
Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech`s COVID-19 vaccine.
Full ArticleThe first phase of the clinical trials for Bharat Biotech's coronavirus disease (COVID-19) vaccine being developed at Post Graduate..